Renal Transplantation in Patients With Positive Lymphocytotoxicity Crossmatches: One Center’s Experience
2008; Wolters Kluwer; Volume: 86; Issue: 1 Linguagem: Inglês
10.1097/tp.0b013e318176ae2c
ISSN1534-6080
AutoresColm Magee, Joana Felgueiras, Kathryn Tinckam, Sayeed K. Malek, Helen Mah, Stefan G. Tullius,
Tópico(s)Pharmacological Effects and Toxicity Studies
ResumoBackground. Sensitization to human leukocyte antigens remains an important barrier to successful renal transplantation. Materials and Methods. Herein we describe our center's experience with a plasmapheresis-based desensitization protocol for highly sensitized patients. Twenty-nine patients had a positive T-cell or positive B-cell lymphocytotoxicity crossmatch against their donors. In some cases, baseline crossmatches were of high titer (e.g., 11 had baseline titers ≥1:32). Results. Twenty-eight of 29 patients were rendered T-cell crossmatch negative and B-cell crossmatch negative/low positive and transplanted. None had hyperacute rejection but 11 (39%) had acute antibody mediated rejection. Median follow-up is 22 months: 25 of the 28 (89%) of allografts are still functioning with mean plasma creatinine 1.5 mg/dL. There was one death because of the transplant or immunsuppression, one case of cytomegalovirus disease and no cases of lymphoproliferative disease. Conclusion. This series provides further evidence of the high efficacy of plasmapheresis-based desensitization protocols. Even patients with high baseline crossmatch titers can be successfully desensitized and transplanted. Short- and medium-term outcomes are encouraging but longer-term data are needed.
Referência(s)